Identification of oncogene mutations in leukemia patients using microchip-based PCR analysis


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅存取

详细

At present, cytogenetic and PCR-based techniques are generally used in the diagnosis of leukemia. Due to high accuracy, specificity, and sensitivity of PCR assays, they have the advantage over traditional cytogenetic tools. As a rule, the classical real time PCR is carried out in a 25-μL reaction mixture. It requires a large volume of each reagent and takes a long time to finish the test. The molecular genetic assay presented here is microchip-based real-time PCR that is optimized for simultaneous analysis of 15 oncogene mutations and one housekeeping gene abl. Moreover, this diagnostic tool requires a minimal amount of cDNA and PCR reagents (10-fold less) and a short time (2-fold less) for quantitative estimation of more than five copies of gene-target. Thus, microchip-based PCR analysis can improve the detection of oncogene mutations in leukemia patients and may be used for both early diagnostics and long-term monitoring of leukemia.

作者简介

K. Bogdanov

Institute of Hematology; Lumex Group

编辑信件的主要联系方式.
Email: kvbogdanov@yandex.ru
俄罗斯联邦, St. Petersburg, 197341; St. Petersburg, 192029

T. Nikulina

Institute of Hematology

Email: kvbogdanov@yandex.ru
俄罗斯联邦, St. Petersburg, 197341

E. Lomaia

Institute of Hematology

Email: kvbogdanov@yandex.ru
俄罗斯联邦, St. Petersburg, 197341

M. Slyadnev

Lumex Group

Email: kvbogdanov@yandex.ru
俄罗斯联邦, St. Petersburg, 192029

A. Zaritskey

Institute of Hematology

Email: kvbogdanov@yandex.ru
俄罗斯联邦, St. Petersburg, 197341

补充文件

附件文件
动作
1. JATS XML

版权所有 © Pleiades Publishing, Ltd., 2017